Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device absorbable coronary drug-eluting stent
Definition An absorbable scaffold with a drug coating placed via a delivery catheter into the coronary artery or saphenous vein graft to maintain the lumen. The drug coating is intended to inhibit restenosis.
Product CodePNY
Device Class 3

MDR Year MDR Reports MDR Events
2021 23 23
2022 7 7
2023 10 10
2024 4 4
2025 16 16
2026 6 6

Device Problems MDRs with this Device Problem Events in those MDRs
Adverse Event Without Identified Device or Use Problem 54 54
Patient-Device Incompatibility 5 5
Break 2 2
Difficult to Advance 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
Thrombosis/Thrombus 26 26
Myocardial Infarction 21 21
Stenosis 16 16
Death 7 7
No Clinical Signs, Symptoms or Conditions 7 7
Thrombosis 7 7
Angina 6 6
Aneurysm 5 5
Perforation of Vessels 4 4
Ischemia 4 4
Unspecified Heart Problem 3 3
Stroke/CVA 3 3
Obstruction/Occlusion 3 3
Cardiac Tamponade 2 2
Hematoma 2 2
Perforation 2 2
Low Blood Pressure/ Hypotension 2 2
Non specific EKG/ECG Changes 1 1
Cardiac Arrest 1 1
Arrhythmia 1 1
Pseudoaneurysm 1 1
Pericardial Effusion 1 1
Unspecified Vascular Problem 1 1
No Consequences Or Impact To Patient 1 1
Transient Ischemic Attack 1 1
Heart Failure/Congestive Heart Failure 1 1
Hemorrhage/Blood Loss/Bleeding 1 1

-
-